leg ulcer
Recently Published Documents


TOTAL DOCUMENTS

986
(FIVE YEARS 164)

H-INDEX

44
(FIVE YEARS 5)

BMJ Open ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. e056790
Author(s):  
Sean Urwin ◽  
Jo C Dumville ◽  
Matt Sutton ◽  
Nicky Cullum

ObjectivesTo estimate and examine the direct healthcare costs of treating people with open venous leg ulcers in the UK.DesignCost-of-illness study.SettingA cross-sectional survey of nine National Health Service community locales over 2-week periods in 2015/2016.MethodsWe examined the resource use and prevalence of venous leg ulcer treatment in the community. Examination of variation in these obtained costs was performed by ordinary least squares regression. We used additional resource use information from a randomised control trial and extrapolated costs to the UK for an annual period.ResultsThe average 2-week per person cost of treating patients where a venous leg ulceration was the primary (most severe) wound was estimated at £166.39 (95% CI £157.78 to £175.00) with community staff time making up over half of this amount. Costs were higher where antimicrobial dressings were used and where wound care was delivered in the home. Among those with any recorded venous leg ulcer (primary and non-primary), we derived a point prevalence of 3.2 per 10 000 population and estimated that the annual prevalence could be no greater than 82.4 per 10 000 population. We estimated that the national cost of treating a venous leg ulcer was £102 million with a per person annual cost at £4787.70.ConclusionOur point prevalence figures are in line with the literature. However, our annual prevalence estimations and costs are far lower than those reported in recent literature which suggests that the costs of treating venous leg ulcers are lower than previously thought. Movement towards routinely collected and useable community care activity would help provide a transparent and deeper understanding of the scale and cost of wound care in the UK.


2021 ◽  
Vol 32 (3) ◽  
pp. 373-376
Author(s):  
Kazuhiko Doi ◽  
Fumie Takai ◽  
Hiromasa Kira ◽  
Koji Ueyama

2021 ◽  
Vol Volume 14 ◽  
pp. 809-814
Author(s):  
Eva Krishna Sutedja ◽  
Retno Hesty Maharani ◽  
Unwati Sugiri ◽  
Pati Aji Achdiat

2021 ◽  
Vol 50 (11) ◽  
pp. 827-829
Author(s):  
John O'Bryen ◽  
Damian Webb
Keyword(s):  

2021 ◽  
Vol 07 ◽  
Author(s):  
Leila Khattabi ◽  
Kawtar Raghay ◽  
Mohamed Dakkach ◽  
Mohamed Allouch

Background: Recent advances in care aware that inadequate management of the healing process in wounds and the development of bacterial infections leads to increase morbidity. Health professionals have progressively recognized the value of choosing suitable dressings to manage wounds particularly in developing countries. Honey has been used for thousands of years as a wound dressing and considered as biologic treatment due to its multiple bioactivities related to healing process. Objective: The aim of this case report is to demonstrate that Argania Honey dressing improve the healing process in a venous leg ulcer. Method: Pure raw Argania honey (Argania spinosa, endemic tree in southwestern of Morocco) with no additives, pasteurization, or manipulation was used and provided from local beekeepers. A mechanical debridement process was achieved previously to the application of honey dressings to a venous leg ulcer of a 67-year-old woman affected by type II diabetes for 11 years. Results : The Argania honey dressing accompanied by mechanical debridement process demonstrated a rapid recovery and complete healing of the wound for 12 weeks approximately (79 days). Conclusion: This Moroccan honey (Argania) experienced for the first time in venous leg ulcer management may represent a good alternative to treat other types of wounds. Further investigations by using Argania honey dressing are required to explain its effect and the mechanisms involved in the improvement of healing process.


Sign in / Sign up

Export Citation Format

Share Document